|

School-based Program for the Prevention of Rheumatic Heart Disease in Endemic Regions

RECRUITINGN/ASponsored by Thomas Pilgrim
Actively Recruiting
PhaseN/A
SponsorThomas Pilgrim
Started2024-12-15
Est. completion2028-02
Eligibility
Age5 Years – 16 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06720272

Summary

The overall objective of the PREVENT trial is to evaluate the effectiveness of an integrated, school-based program for the prevention of rheumatic heart disease (RHD) in regions with an endemic pattern of RHD. We conduct a stepped wedge cluster randomized trial in randomly selected schools in Nepal and Zambia. The intervention will be delivered at the level of the school and consists in the introduction of a dedicated school-nurse program providing health care through education about RHD, assessment, intervention, and follow-up of GABHS pharyngitis, and facilitation of secondary antibiotic prophylaxis for children with RHD.

Eligibility

Age: 5 Years – 16 YearsHealthy volunteers accepted
Inclusion Criteria:

\- Children aged 5-16 years

Exclusion Criteria:

* Children / primary caregivers not providing informed consent to participate
* Children not attending one of the selected schools

Conditions3

ArthritisHeart DiseaseRheumatic Heart Disease in Children

Browse More Trials

Heart Disease trialsArthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.